LCM
PRVL

Laurion Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Laurion Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-101,949
Closed -$1.25M – 918
2019
Q3 		$1.25M Sell
101,949
-98,051
-49% -$1.2M 0.01% 243
2019
Q2 		$2.64M Buy
+200,000
New +$2.64M 0.03% 98